Albuterol HFA MDI in Pediatric Participants With Asthma

Completed · Phase 3 · Has a placebo group

Conditions studied: Asthma

In brief

The primary objective of this study is to evaluate the chronic-dose and efficacy of Albuterol-HFA-MDI relative to placebo in pediatric asthmatics.

Key facts

Study ID
NCT00577655
Run by
Teva Branded Pharmaceutical Products R&D, Inc.
People needed
103
Starts
2007-08-01
Expected to finish
2008-07-01
Last updated by the study team
2021-11-12

Who can join

Age: 4 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.